Rupert Bartsch

Research interests

Publications

• Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b/4 trial

  Nature Medicine · 2024 · https://doi.org/10.1038/s41591-024-03261-7

• Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

  Annals of Oncology · 2022 · https://doi.org/10.1016/j.annonc.2022.09.159

• Trastuzumab deruxtecan in HER2-positive breast cancer with brain metastases: a single-arm, phase 2 trial

  Nature Medicine · 2022 · https://doi.org/10.1038/s41591-022-01935-8

• Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast Cancer

  New England Journal of Medicine · 2021 · https://doi.org/10.1056/nejmoa2104162

• Pembrolizumab plus trastuzumab in trastuzumab-resistant, advanced, HER2-positive breast cancer (PANACEA): a single-arm, multicentre, phase 1b–2 trial

  The Lancet Oncology · 2019 · https://doi.org/10.1016/s1470-2045(18)30812-x

• Impact of Machine Learning With Multiparametric Magnetic Resonance Imaging of the Breast for Early Prediction of Response to Neoadjuvant Chemotherapy and Survival Outcomes in Breast Cancer Patients

  Investigative Radiology · 2018 · https://doi.org/10.1097/rli.0000000000000518

• Impact of Breast Surgery in Primary Metastasized Breast Cancer

  Annals of Surgery · 2018 · https://doi.org/10.1097/sla.0000000000002771

• Survival prediction using temporal muscle thickness measurements on cranial magnetic resonance images in patients with newly diagnosed brain metastases

  European Radiology · 2017 · https://doi.org/10.1007/s00330-016-4707-6

• Tumor infiltrating lymphocytes and PD-L1 expression in brain metastases of small cell lung cancer (SCLC)

  Journal of Neuro-Oncology · 2016 · https://doi.org/10.1007/s11060-016-2216-8

• Descriptive statistical analysis of a real life cohort of 2419 patients with brain metastases of solid cancers

  ESMO Open · 2016 · https://doi.org/10.1136/esmoopen-2015-000024

• Activity of T-DM1 in Her2-positive breast cancer brain metastases

  Clinical & Experimental Metastasis · 2015 · https://doi.org/10.1007/s10585-015-9740-3

• Density of tumor-infiltrating lymphocytes correlates with extent of brain edema and overall survival time in patients with brain metastases

  OncoImmunology · 2015 · https://doi.org/10.1080/2162402x.2015.1057388

• Improved Diagnostic Accuracy With Multiparametric Magnetic Resonance Imaging of the Breast Using Dynamic Contrast-Enhanced Magnetic Resonance Imaging, Diffusion-Weighted Imaging, and 3-Dimensional Proton Magnetic Resonance Spectroscopic Imaging

  Investigative Radiology · 2014 · https://doi.org/10.1097/rli.0000000000000029

• Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12

  Annals of Oncology · 2014 · https://doi.org/10.1093/annonc/mdu544

• Invasion patterns in brain metastases of solid cancers

  Neuro-Oncology · 2013 · https://doi.org/10.1093/neuonc/not112

• Trastuzumab mediates antibody-dependent cell-mediated cytotoxicity and phagocytosis to the same extent in both adjuvant and metastatic HER2/neu breast cancer patients

  Journal of Translational Medicine · 2013 · https://doi.org/10.1186/1479-5876-11-307

• Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone

  Annals of Oncology · 2013 · https://doi.org/10.1093/annonc/mdt494

• Intrathecal administration of trastuzumab for the treatment of meningeal carcinomatosis in HER2-positive metastatic breast cancer: a systematic review and pooled analysis

  Breast Cancer Research and Treatment · 2013 · https://doi.org/10.1007/s10549-013-2525-y

• Trastuzumab administration during pregnancy: a systematic review and meta-analysis

  Breast Cancer Research and Treatment · 2012 · https://doi.org/10.1007/s10549-012-2368-y

• Brain metastases: pathobiology and emerging targeted therapies

  Acta Neuropathologica · 2012 · https://doi.org/10.1007/s00401-011-0933-9

• Triple-negative breast cancer

  Wiener Medizinische Wochenschrift · 2010 · https://doi.org/10.1007/s10354-010-0773-6

• A virosomal formulated Her-2/neu multi-peptide vaccine induces Her-2/neu-specific immune responses in patients with metastatic breast cancer: a phase I study

  Breast Cancer Research and Treatment · 2009 · https://doi.org/10.1007/s10549-009-0666-9

• Trastuzumab prolongs overall survival in patients with brain metastases from Her2 positive breast cancer

  Journal of Neuro-Oncology · 2007 · https://doi.org/10.1007/s11060-007-9420-5

• Capecitabine and Trastuzumab in Heavily Pretreated Metastatic Breast Cancer

  Journal of Clinical Oncology · 2007 · https://doi.org/10.1200/jco.2007.11.9776

• Comparison of nested PCR with immunofluorescent-antibody assay for detection of Ehrlichia canis infection in dogs treated with doxycycline

  Journal of Clinical Microbiology · 1997 · https://doi.org/10.1128/jcm.35.7.1852-1855.1997

Current projects

No projects listed.